Brigitt Raux
Marseille, 13009, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Unexpected Noncovalent Off-Target Activity of Clinical BTK Inhibitors Leads to Discovery of a Dual NUDT5/14 Antagonist.
Journal: Journal of medicinal chemistry
Published: April 18, 2024
Discovery of PFI-6, a small-molecule chemical probe for the YEATS domain of MLLT1 and MLLT3.
Journal: Bioorganic & medicinal chemistry letters
Published: August 31, 2023
Discovery of High-Affinity Small-Molecule Binders of the Epigenetic Reader YEATS4.
Journal: Journal of medicinal chemistry
Published: December 23, 2022
GRID1/GluD1 homozygous variants linked to intellectual disability and spastic paraplegia impair mGlu1/5 receptor signaling and excitatory synapses.
Journal: Molecular psychiatry
Published: June 09, 2022
Integrated Strategy for Lead Optimization Based on Fragment Growing: The Diversity-Oriented-Target-Focused-Synthesis Approach.
Journal: Journal of medicinal chemistry
Published: June 09, 2018
Protein-Protein Interaction Inhibition (2P2I)-Oriented Chemical Library Accelerates Hit Discovery.
Journal: ACS chemical biology
Published: May 25, 2016
Slowing down fat digestion and absorption by an oxadiazolone inhibitor targeting selectively gastric lipolysis.
Journal: European journal of medicinal chemistry
Published: May 09, 2016
Exploring Selective Inhibition of the First Bromodomain of the Human Bromodomain and Extra-terminal Domain (BET) Proteins.
Journal: Journal of medicinal chemistry
Published: January 07, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026